Şunu aradınız:: kolistimetat (Slovence - İngilizce)

kolistimetat natrij
colistimethate sodium

colobreathe natrijev kolistimetat
colobreathe colistimethate sodium

zdravilna učinkovina je natrijev kolistimetat.
the active substance is colistimethate sodium.

natrijev kolistimetat se in vivo pretvori v kolistin.
colistimethate sodium is converted to the base in vivo.

natrijev kolistimetat se lahko izloča v materino mleko.
colistimethate sodium may be secreted in the breast milk.

colobreathe je zdravilo, ki vsebuje zdravilno učinkovino natrijev kolistimetat.
colobreathe is a medicine that contains the active substance colistimethate sodium.

natrijev kolistimetat je treba uporabljati izredno previdno pri bolnikih s porfirijo.
colistimethate sodium should be used with extreme caution in patients with porphyria.

zdravilo colobreathe vsebuje natrijev kolistimetat, vrsto antibiotika, imenovanega polimiksin.
colobreathe contains colistimethate sodium, a type of antibiotic called a polymyxin.

natrijev kolistimetat nima opaznih učinkov na plodnost pri podganjih in mišjih samcih ter samicah.
colistimethate sodium has no notable effects on fertility in male or female rats or mice.

colobreathe 1.662.500 i.e. prašek za inhaliranje, trde kapsule natrijev kolistimetat
colobreathe 1,662,500 iu inhalation powder, hard capsules colistimethate sodium

med uporabo zdravila bronchitol lahko še naprej uporabljate svoja zdravila za cistično fibrozo, tudi antibiotike za inhaliranje, kot sta tobramicin in natrijev kolistimetat.
you can carry on using your medicines for cystic fibrosis when you are using bronchitol, this includes inhaled antibiotics such as tobramycin and colistimethate sodium.

Študije enkratnega intravenskega odmerka pri nosečnicah kažejo, da natrijev kolistimetat prehaja skozi placento, zato obstaja možnost toksičnosti za plod, če se daje med nosečnostjo.
single dose intravenous studies in human pregnancy show that colistimethate sodium crosses the placenta and consequently there is potential for foetal toxicity if administered during pregnancy.

zdravila colobreathe ne smejo uporabljati osebe, ki utegnejo biti preobčutljive za (alergične na) natrijev kolistimetat, kolistinijev sulfat ali polimiksin b.
colobreathe must not be used in people who are hypersensitive (allergic) to colistimethate sodium or to colistin sulphate or polymyxin b.

natrijev kolistimetat in kolistin so raziskali in vitro, da bi ugotovili učinke na ekspresijo encimov citokroma p450 (cyp) z obdelavo primarnih kultur svežih humanih hepatocitov.
colistimethate sodium and colistin have been investigated in vitro to determine the effects on the expression of cytochrome p450 (cyp) enzymes on treating primary cultures of fresh human hepatocytes.

kaj morate vedeti, preden boste uporabili zdravilo colobreathe ne uporabljajte zdravila colobreathe: če ste vi/vaš otrok alergični na natrijev kolistimetat, kolistinijev sulfat ali polimiksine.
what you need to know before you use colobreathe do not use colobreathe: if you/your child are allergic to colistimethate sodium, colistin sulphate or polymyxins.

natrijev kolistimetat je dobro znan antibiotik, ki se že mnoga leta uporablja za zdravljenje pljučne okužbe pri bolnikih s cistično fibrozo, in je na razpolago v obliki raztopine, ki se uporablja z nebulatorjem (pripomočkom, ki raztopino spremeni v aerosol, kar bolniku omogoči inhalacijo).
colistimethate sodium is a well-known antibiotic that has been used for several years to treat lung infection in cystic fibrosis patients and is available in the form of a solution used with a nebuliser (a machine that changes a solution into an aerosol that the patient can breathe in).